Eight patients with total sixth nerve palsy were treated with botulinum toxin injec tion to the antagonist non-paretic medical rectus, within eight weeks of the onset of the palsy. Within a few day s seven of the eight gained fusion without the necessity of a marked head turn, and none complained of confusing reversal of diplopia. The same seven recovered full function. The mean follow-up period after the last injection was 20 months.
Summary
Eight patients with total sixth nerve palsy were treated with botulinum toxin injec tion to the antagonist non-paretic medical rectus, within eight weeks of the onset of the palsy. Within a few day s seven of the eight gained fusion without the necessity of a marked head turn, and none complained of confusing reversal of diplopia. The same seven recovered full function. The mean follow-up period after the last injection was 20 months.
Seven palsies were the result of head trauma and one was due to cerebro-vascular disease.
This preliminary report suggests that early botulinum toxin injection of patients with recent onset sixth nerve palsy is beneficial. Although all of the patients may possibly have recovered full lateral rectus function without treatment, the aetiologies of their palsies were of the ty pe that frequently do no resolve. A randomised double blind study is necessary more precisely to determine the effectiveness of this form of therapy.
The sudden onset of a sixth nerve p alsy usually results in debilitating horizontal di p lo pia. To determine whether sym p tomatic di p lo p ia in p rimary gaze can be diminished early on, a grou p of p atients with total sixth nerve palsy were injected with botulinum toxin. The effects u p on the deviation and extent of abduction, as well as the p atients' subjective res p onse to medial rectus p aralysis were assessed.
Patients and Methods
Eight p atients (all males) with total sixth nerve p alsy were treated with botulinum toxin injection to the antagonistic non-p aretic The results are summarised in Table I . The pre-injection angle of esotropia aver aged 38 prism dioptres (range 30-55 prism dioptres). No patient in this series had any lat eral rectus function before injection, no patient could abduct beyond the midline and no patient had any contracture of the medial rectus.
Within a few days of injection, seven (cases 2 to 8) of the eight patients regained fusion, without the necessity of a marked head turn. The same seven patients required only one injection and eventually regained full function with normal abduction and no residual devia tion. One patient (case 1) who was injected four times over a 24-month period, had no recovery of sixth never function, and required surgery. No patients were bothered by reversal of diplopia as the botulinum toxin injection took effect and all experienced a marked symp tomatic improvement.
Complications
Five patients (cases 1, 3, 4, 5, 8) developed transient mild ptosis which resolved com pletely within eight weeks. The patient (case 1) who was injected four times, developed a small permanent vertical deviation. No systemic side effect occurred in any patient at any time during the study.
Discussion
Early injection of botulinum to the ipsilateral medial rectus allowed seven of our eight patients to enjoy and appreciate fusion in or close to the primary position, without the necessity of a marked head turn. Metz and Mazowl and Wagner and Frohman2 reported Table I . Pre and post-injection findings a marked symptomatic improvement in similar groups of patients who were injected within 12 weeks of the onset of the palsy. Elston,3 and Elston and Lee4 initially expressed a strong argument against the use of botulinum in the acute phase of 6th nerve palsy, believing that paralysis of the medial rectus would lead to a confusing reversal of diplopia. However they have recently accepted that botulinum does in fact play a useful role in the symptomatic management of this condition.5
The prognosis for recovery of function over two or three months is excellent in most cases due to microvascular disease, and we recog nise that some patients will improve or recover spontaneously without botulinum.
However, Rush and Younge6 in reviewing 419 cases of sixth nerve palsy found that irres pective of aetiology, only 49% of patients spontaneously recovered full function (Table  II) .
As some patients, including those with microvascular disease, will not recover spon taneously, and as this group cannot always reliably be identified in the acute stage, our results lead us to recommend early treatment of patients showing no signs of recovery two months after the onset of the palsy. Diplopia in primary gaze may be avoided, occlusion may not be necessary, and the chance of medial rectus contracture is markedly reduced. Injection at an even earlier stage may be beneficial, and we are currently eval uating patients who were injected at one month, after they had shown no improvement by then.
An unexpectedly high number of our patients (87%) and of Metz and Mazow'sl 
Conclusion
Botulinum toxin p lays a useful role in the early symptomatic management of lateral rectus p alsy. Whether it facilitates the recovery of sixth nerve function has yet to be determined.
